An Official Website of the United States Government
Company Information:
Name:
DISCOVERYBIOMED, LLC
Address:
400 Riverhills Business Park
BIRMINGHAM, AL 35242-8101
BIRMINGHAM, AL 35242-8101
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$100,000.00
Abstract:
DESCRIPTION (provided by applicant): Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis Scientific Summary Description Hypertension is a confounding multifactorial disorder that affects millions of patients worldwide. Cystic fibrosis (CF) is
an inherited disease of the pulmonary and… More
Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis
Award Year / Program / Phase:
2009 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Erik M. Schwiebert
Award Amount:
$746,326.00
Abstract:
DESCRIPTION (provided by applicant): Hypertension is a confounding multifactorial disorder that affects millions of patients worldwide. Cystic fibrosis (CF) is an inherited disease of the pulmonary and gastrointestinal systems that presents in pediatric an
d young adult populations. What do… More
Cystic Fibrosis Corrector Ligands Discovered in CF Human Airway Cells
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Erik M. Schwiebert
Award Amount:
$322,000.00
Abstract:
DESCRIPTION (provided by applicant): In this proposed Phase I SBIR program, DiscoveryBioMed, Inc. (DBM) will continue to build upon an active project performed in collaboration with CFTR cell biologists at the University of Alabama at Birmingham and altern
ative rescue chloride (Cl-) channel… More
Discovery of Inhibitors of PTH-Wnt Signaling Synergy in Bone Cells
Award Year / Program / Phase:
2010 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Erik M. Schwiebert
Award Amount:
$234,330.00
Abstract:
DESCRIPTION (provided by applicant): Project Summary Description Title: Discovery of Inhibitors of PTH-Wnt Signaling Synergy in Bone Cells. Osteoporosis is a growing problem in the aged and an unfortunately large disease market and burden to the healthcare
industry. This debilitating disease costs … More
CF Corrector Ligands Discovered on CF Human Airway Cells
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Erik M. Schwiebert – 205-934-6234
Award Amount:
$1,379,561.00
Abstract:
DESCRIPTION (provided by applicant): DiscoveryBioMed, Inc. (DBM) achieved Phase 1 SBIR milestones and seeks to continue a mature program that has progressed to the hit-to-lead drug validation, prioritization and progression stage. DBM s major over-archinggoal for this program is to identify novel… More
Human Adipocyte Platform for Discovery of Novel Adiponectin Secretagogues
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Eric C. Seales – 205-307-6535
Award Amount:
$221,853.00
Abstract:
DESCRIPTION (provided by applicant): Small business concerns, DiscoveryBioMed, Inc. (DBM) and Chromadex, Inc. (CDex), have designed an innovative automation-friendly drug discovery program to screen medicinal plant-derived phytochemicals and extract fractions on an immortalized human adipocyte… More